clinical trial · NCT07684456
Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.·phase3·not yet recruiting·n = 308
Advanced Breast CancerUtidelone CapsuleUtidelone InjectionCapecitabine
brief summary
This study is a randomized controlled study.The primary objective is to evaluate the Progression-Free Survival(PFS) of Utidelone Capsule combined with Capecitabine compared with Utidelone Injection combined with Capecitabine in patients with HER-2 negative advanced breast cancer.
started
Aug 1, 2026
primary completion
Mar 1, 2028
completion
Mar 1, 2029
last updated
Jul 6, 2026
official title
A Randomized,Controlled Phase III Study on Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol